Kaleido

Developer of insulin therapy for treating diabetes

placeUtrecht, Utrecht, Netherlands calendar_todayFounded 2013 groups129 employees language hellokaleido.com

Social engagement

Social engagement: 10.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Partners in Equity, Life Sciences Partners, Inkef, Invest-NL.

Investor typeCountShare
Venture capital433%
Private equity433%
Bank & private debt18%
Other / undisclosed325%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

20 Jan 2025 · Senior Project Manager Manufacturing · Utrecht

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Product launch
DBLG2 Demo Application
30 Jun 2026
Event
exclusive webinar on DiabetesCare
24 Jun 2026
Event
exclusive webinar on diabetes teams
Coming soon